10 20 30 40 50 60 70 80 2HHD - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER OXYGEN TRANSPORT 29-SEP-94 2HHD
TITLE OXYGEN AFFINITY MODULATION BY THE N-TERMINI OF THE BETA- TITLE 2 CHAINS IN HUMAN AND BOVINE HEMOGLOBIN
COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEMOGLOBIN (DEOXY) (ALPHA CHAIN); COMPND 3 CHAIN: A, C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HEMOGLOBIN (DEOXY) (BETA CHAIN); COMPND 7 CHAIN: B, D; COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: BLOOD; SOURCE 6 TISSUE: BLOOD; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 ORGAN: BLOOD; SOURCE 12 TISSUE: BLOOD
KEYWDS OXYGEN TRANSPORT
EXPDTA X-RAY DIFFRACTION
AUTHOR G.L.GILLILAND,I.PECHIK,C.FRONTICELLI,X.JI
REVDAT 2 24-FEB-09 2HHD 1 VERSN REVDAT 1 26-JAN-95 2HHD 0
JRNL AUTH I.PECHIK,X.JI,K.FIDELIS,M.KARAVITIS,J.MOULT, JRNL AUTH 2 W.S.BRINIGAR,C.FRONTICELLI,G.L.GILLILAND JRNL TITL CRYSTALLOGRAPHIC, MOLECULAR MODELING, AND JRNL TITL 2 BIOPHYSICAL CHARACTERIZATION OF THE VALINE BETA 67 JRNL TITL 3 (E11)-->THREONINE VARIANT OF HEMOGLOBIN. JRNL REF BIOCHEMISTRY V. 35 1935 1996 JRNL REFN ISSN 0006-2960 JRNL PMID 8639677 JRNL DOI 10.1021/BI9519967
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROLSQ REMARK 3 AUTHORS : KONNERT,HENDRICKSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 21076 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.137 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4384 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 182 REMARK 3 SOLVENT ATOMS : 474 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.016 ; 0.020 REMARK 3 ANGLE DISTANCE (A) : 0.038 ; 0.036 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.038 ; 0.040 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.023 ; 0.030 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.190 ; 0.200 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.195 ; 0.300 REMARK 3 MULTIPLE TORSION (A) : 0.207 ; 0.300 REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : 0.175 ; 0.300 REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 3.500 ; 5.000 REMARK 3 STAGGERED (DEGREES) : 18.500; 15.000 REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.787 ; 1.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.310 ; 1.500 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.398 ; 1.500 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.193 ; 2.000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2HHD COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27357 REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.06500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -137.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 450 REMARK 450 SOURCE REMARK 450 REMARK 450 PURIFIED FROM OUTDATED BLOOD OBTAINED FROM THE BLOOD REMARK 450 BANK OF THE UNIVERSITY OF MARYLAND
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 6 O - C - N ANGL. DEV. = 10.9 DEGREES REMARK 500 ARG A 31 NE - CZ - NH1 ANGL. DEV. = 4.3 DEGREES REMARK 500 ARG A 31 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 MET A 76 CG - SD - CE ANGL. DEV. = 9.9 DEGREES REMARK 500 ARG A 92 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG A 92 NE - CZ - NH2 ANGL. DEV. = -6.4 DEGREES REMARK 500 LEU A 105 CA - CB - CG ANGL. DEV. = 14.7 DEGREES REMARK 500 LEU B 14 CA - CB - CG ANGL. DEV. = 14.8 DEGREES REMARK 500 ARG B 30 NH1 - CZ - NH2 ANGL. DEV. = 7.4 DEGREES REMARK 500 ARG B 30 NE - CZ - NH2 ANGL. DEV. = -5.8 DEGREES REMARK 500 ARG B 40 NE - CZ - NH1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP B 52 CB - CG - OD2 ANGL. DEV. = -5.4 DEGREES REMARK 500 LEU B 68 CA - CB - CG ANGL. DEV. = 14.5 DEGREES REMARK 500 ASP B 94 CB - CG - OD1 ANGL. DEV. = 6.6 DEGREES REMARK 500 ASP B 94 CB - CG - OD2 ANGL. DEV. = -8.6 DEGREES REMARK 500 TYR B 145 CB - CG - CD1 ANGL. DEV. = -4.6 DEGREES REMARK 500 ASP C 6 CB - CG - OD2 ANGL. DEV. = -9.0 DEGREES REMARK 500 ARG C 31 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG C 31 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 ASP C 64 CB - CG - OD1 ANGL. DEV. = 8.6 DEGREES REMARK 500 ASP C 64 CB - CG - OD2 ANGL. DEV. = -5.8 DEGREES REMARK 500 ASP C 74 CB - CG - OD2 ANGL. DEV. = 7.9 DEGREES REMARK 500 ASP C 85 CB - CG - OD2 ANGL. DEV. = -5.8 DEGREES REMARK 500 HIS C 89 CA - CB - CG ANGL. DEV. = -10.3 DEGREES REMARK 500 ARG C 92 CD - NE - CZ ANGL. DEV. = 12.4 DEGREES REMARK 500 ARG C 92 NE - CZ - NH1 ANGL. DEV. = 5.3 DEGREES REMARK 500 ARG C 92 NE - CZ - NH2 ANGL. DEV. = -6.6 DEGREES REMARK 500 ALA C 130 CB - CA - C ANGL. DEV. = 10.3 DEGREES REMARK 500 ARG C 141 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 ARG D 30 NE - CZ - NH2 ANGL. DEV. = -5.0 DEGREES REMARK 500 ARG D 40 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 ALA D 70 CB - CA - C ANGL. DEV. = 9.5 DEGREES REMARK 500 ASP D 79 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP D 99 CB - CG - OD2 ANGL. DEV. = 6.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 75 58.52 -172.69 REMARK 500 LEU A 113 74.35 -117.12 REMARK 500 ASP C 75 43.10 -150.03 REMARK 500 PHE C 117 62.56 -69.67 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 179 DISTANCE = 5.45 ANGSTROMS REMARK 525 HOH A 203 DISTANCE = 5.52 ANGSTROMS REMARK 525 HOH C 221 DISTANCE = 5.01 ANGSTROMS REMARK 525 HOH C 236 DISTANCE = 7.10 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 D 147 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 147 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 142 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 148 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM C 142 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM D 148
DBREF 2HHD A 1 141 UNP P01922 HBA_HUMAN 1 141 DBREF 2HHD B 1 146 UNP P68871 HBB_HUMAN 1 146 DBREF 2HHD C 1 141 UNP P01922 HBA_HUMAN 1 141 DBREF 2HHD D 1 146 UNP P68871 HBB_HUMAN 1 146
SEQRES 1 A 141 VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 A 141 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 A 141 GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 A 141 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 A 141 ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP ALA SEQRES 6 A 141 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 A 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 A 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 A 141 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 A 141 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 A 141 SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 B 146 VAL HIS LEU THR PRO GLU GLU LYS SER ALA VAL THR ALA SEQRES 2 B 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 B 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 B 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 B 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 B 146 LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 B 146 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 B 146 HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 B 146 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 B 146 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 B 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 B 146 LYS TYR HIS SEQRES 1 C 141 VAL LEU SER PRO ALA ASP LYS THR ASN VAL LYS ALA ALA SEQRES 2 C 141 TRP GLY LYS VAL GLY ALA HIS ALA GLY GLU TYR GLY ALA SEQRES 3 C 141 GLU ALA LEU GLU ARG MET PHE LEU SER PHE PRO THR THR SEQRES 4 C 141 LYS THR TYR PHE PRO HIS PHE ASP LEU SER HIS GLY SER SEQRES 5 C 141 ALA GLN VAL LYS GLY HIS GLY LYS LYS VAL ALA ASP ALA SEQRES 6 C 141 LEU THR ASN ALA VAL ALA HIS VAL ASP ASP MET PRO ASN SEQRES 7 C 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 C 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 C 141 LEU LEU VAL THR LEU ALA ALA HIS LEU PRO ALA GLU PHE SEQRES 10 C 141 THR PRO ALA VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 C 141 SER VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 D 146 VAL HIS LEU THR PRO GLU GLU LYS SER ALA VAL THR ALA SEQRES 2 D 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 D 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 D 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER THR PRO ASP SEQRES 5 D 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 D 146 LYS VAL LEU GLY ALA PHE SER ASP GLY LEU ALA HIS LEU SEQRES 7 D 146 ASP ASN LEU LYS GLY THR PHE ALA THR LEU SER GLU LEU SEQRES 8 D 146 HIS CYS ASP LYS LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 D 146 LEU LEU GLY ASN VAL LEU VAL CYS VAL LEU ALA HIS HIS SEQRES 10 D 146 PHE GLY LYS GLU PHE THR PRO PRO VAL GLN ALA ALA TYR SEQRES 11 D 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 D 146 LYS TYR HIS
HET SO4 D 147 5 HET SO4 B 147 5 HET HEM A 142 43 HET HEM B 148 43 HET HEM C 142 43 HET HEM D 148 43
HETNAM SO4 SULFATE ION HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE
HETSYN HEM HEME
FORMUL 5 SO4 2(O4 S 2-) FORMUL 7 HEM 4(C34 H32 FE N4 O4) FORMUL 11 HOH *474(H2 O)
HELIX 1 1 SER A 3 GLY A 18 1 16 HELIX 2 2 HIS A 20 PHE A 36 1 17 HELIX 3 3 PRO A 37 PHE A 43 5 7 HELIX 4 4 SER A 52 HIS A 72 1 21 HELIX 5 5 ASP A 75 LEU A 80 1 6 HELIX 6 6 LEU A 80 LYS A 90 1 11 HELIX 7 7 ASP A 94 LEU A 113 1 20 HELIX 8 8 THR A 118 SER A 138 1 21 HELIX 9 9 THR B 4 GLY B 16 1 13 HELIX 10 10 ASN B 19 TYR B 35 1 17 HELIX 11 11 PRO B 36 GLU B 43 5 8 HELIX 12 12 PHE B 42 GLY B 46 5 5 HELIX 13 13 THR B 50 ASN B 57 1 8 HELIX 14 14 ASN B 57 LEU B 75 1 19 HELIX 15 15 ALA B 76 LEU B 78 5 3 HELIX 16 16 ASN B 80 LYS B 95 1 16 HELIX 17 17 PRO B 100 GLY B 119 1 20 HELIX 18 18 LYS B 120 PHE B 122 5 3 HELIX 19 19 THR B 123 ALA B 142 1 20 HELIX 20 20 SER C 3 GLY C 18 1 16 HELIX 21 21 HIS C 20 PHE C 36 1 17 HELIX 22 22 PRO C 37 PHE C 43 5 7 HELIX 23 23 SER C 52 HIS C 72 1 21 HELIX 24 24 ASP C 75 LEU C 80 1 6 HELIX 25 25 LEU C 80 LYS C 90 1 11 HELIX 26 26 VAL C 96 LEU C 113 1 18 HELIX 27 27 THR C 118 SER C 138 1 21 HELIX 28 28 THR D 4 VAL D 18 1 15 HELIX 29 29 ASN D 19 TYR D 35 1 17 HELIX 30 30 PRO D 36 PHE D 42 5 7 HELIX 31 31 PHE D 42 GLY D 46 5 5 HELIX 32 32 THR D 50 GLY D 56 1 7 HELIX 33 33 ASN D 57 ALA D 76 1 20 HELIX 34 34 HIS D 77 ASP D 79 5 3 HELIX 35 35 ASN D 80 LYS D 95 1 16 HELIX 36 36 PRO D 100 GLY D 119 1 20 HELIX 37 37 LYS D 120 PHE D 122 5 3 HELIX 38 38 THR D 123 HIS D 143 1 21
LINK FE HEM A 142 NE2 HIS A 87 1555 1555 2.30 LINK FE HEM B 148 NE2 HIS B 92 1555 1555 2.40 LINK FE HEM C 142 NE2 HIS C 87 1555 1555 2.30 LINK FE HEM D 148 NE2 HIS D 92 1555 1555 2.38
SITE 1 AC1 7 VAL D 1 LEU D 78 ASP D 79 ASN D 80 SITE 2 AC1 7 LEU D 81 LYS D 82 HOH D 149 SITE 1 AC2 5 VAL B 1 LEU B 78 LEU B 81 LYS B 82 SITE 2 AC2 5 HOH B 177 SITE 1 AC3 16 TYR A 42 PHE A 43 HIS A 45 PHE A 46 SITE 2 AC3 16 HIS A 58 LYS A 61 LEU A 83 LEU A 86 SITE 3 AC3 16 HIS A 87 LEU A 91 VAL A 93 ASN A 97 SITE 4 AC3 16 PHE A 98 LEU A 101 LEU A 136 HOH A 194 SITE 1 AC4 18 ALA A 53 HOH A 197 PHE B 41 PHE B 42 SITE 2 AC4 18 HIS B 63 LYS B 66 VAL B 67 ALA B 70 SITE 3 AC4 18 LEU B 88 LEU B 91 HIS B 92 LEU B 96 SITE 4 AC4 18 ASN B 102 PHE B 103 LEU B 106 LEU B 141 SITE 5 AC4 18 HOH B 161 HOH B 206 SITE 1 AC5 15 TYR C 42 PHE C 43 HIS C 45 PHE C 46 SITE 2 AC5 15 HIS C 58 LYS C 61 LEU C 83 LEU C 86 SITE 3 AC5 15 HIS C 87 LEU C 91 VAL C 93 ASN C 97 SITE 4 AC5 15 PHE C 98 LEU C 136 HOH C 152 SITE 1 AC6 13 PHE D 41 PHE D 42 HIS D 63 VAL D 67 SITE 2 AC6 13 ALA D 70 LEU D 88 HIS D 92 LEU D 96 SITE 3 AC6 13 VAL D 98 ASN D 102 PHE D 103 LEU D 106 SITE 4 AC6 13 LEU D 141
CRYST1 62.450 82.130 53.760 90.00 98.87 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.016013 0.000000 0.002499 0.00000
SCALE2 0.000000 0.012176 0.000000 0.00000
SCALE3 0.000000 0.000000 0.018826 0.00000